SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4.12 |
| Enterprise Value ($M) | 0.98 |
| Book Value ($M) | 3.38 |
| Book Value / Share | 2.41 |
| Price / Book | 1.22 |
| NCAV ($M) | 3.13 |
| NCAV / Share | 2.23 |
| Price / NCAV | 1.32 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.96 |
| Return on Assets (ROA) | -1.57 |
| Return on Equity (ROE) | -2.33 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.42 |
| Current Ratio | 2.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5.34 |
| Assets | 5.60 |
| Liabilities | 2.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 5.21 |
| Operating Income | -6.73 |
| Net Income | -7.99 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -7.50 |
| Cash from Investing | 0.00 |
| Cash from Financing | 9.88 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Perceptive Advisors Llc | 5.30 | 0.00 | |
| 13G | Anson Funds Management LP | 7.10 | ||
| 13G | Ra Capital Management, L.p. | 9.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 74,790 | 341,556 | 21.90 | |
| 71,003 | 345,943 | 20.52 | |
| 225,984 | 867,159 | 26.06 | |
| 329,846 | 1,156,405 | 28.52 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELTX – Elicio Therapeutics, Inc. | ELUT – Elutia Inc. |
| ENLV – Enlivex Therapeutics Ltd. | ENTO – Entero Therapeutics, Inc. |
| ENTX – Entera Bio Ltd. |
Financial data and stock pages provided by
Fintel.io